Difficulty: Medium
Average Score: 62%
Practice
Which of the following is true of acyclovir treatment of genital herpes simplex?
Correct answer
C
Rationale
The correct answer is C) Oral therapy for 10 days affords symptomatic relief but does not prevent recurrences.
Rationale:
Acyclovir is an antiviral medication commonly used to treat genital herpes simplex. While oral therapy with acyclovir can help alleviate symptoms during an outbreak, it does not eradicate the virus from the body. Therefore, it does not prevent future recurrences of the infection. The 10-day oral therapy regimen is typically aimed at reducing the severity and duration of the current outbreak rather than providing long-term prevention.
Explanation of Incorrect Options:
A) Topical treatment affords symptomatic relief in primary as well as recurrent disease - This statement is incorrect as topical acyclovir is not typically used for genital herpes simplex; oral therapy is the primary treatment.
B) Oral therapy for 10 days affords symptomatic relief as well as prevents recurrences - This option is incorrect because, as explained earlier, acyclovir does not prevent recurrences with short-term therapy.
D) Continuous long-term topical therapy is recommended to prevent recurrences - This option is incorrect as continuous long-term topical therapy is not the standard recommendation for preventing recurrences of genital herpes simplex.
Educational Context:
Understanding the appropriate use of antiviral medications like acyclovir is crucial for healthcare professionals, especially those preparing for exams like the NCLEX. Knowing the limitations and expected outcomes of treatment regimens helps ensure safe and effective care for patients with genital herpes simplex infections. It also highlights the importance of patient education regarding the nature of the disease and the role of medications in managing symptoms and preventing future outbreaks.
Rationale:
Acyclovir is an antiviral medication commonly used to treat genital herpes simplex. While oral therapy with acyclovir can help alleviate symptoms during an outbreak, it does not eradicate the virus from the body. Therefore, it does not prevent future recurrences of the infection. The 10-day oral therapy regimen is typically aimed at reducing the severity and duration of the current outbreak rather than providing long-term prevention.
Explanation of Incorrect Options:
A) Topical treatment affords symptomatic relief in primary as well as recurrent disease - This statement is incorrect as topical acyclovir is not typically used for genital herpes simplex; oral therapy is the primary treatment.
B) Oral therapy for 10 days affords symptomatic relief as well as prevents recurrences - This option is incorrect because, as explained earlier, acyclovir does not prevent recurrences with short-term therapy.
D) Continuous long-term topical therapy is recommended to prevent recurrences - This option is incorrect as continuous long-term topical therapy is not the standard recommendation for preventing recurrences of genital herpes simplex.
Educational Context:
Understanding the appropriate use of antiviral medications like acyclovir is crucial for healthcare professionals, especially those preparing for exams like the NCLEX. Knowing the limitations and expected outcomes of treatment regimens helps ensure safe and effective care for patients with genital herpes simplex infections. It also highlights the importance of patient education regarding the nature of the disease and the role of medications in managing symptoms and preventing future outbreaks.